Table 2.
The most common adverse events associated with lenalidomide plus rituximab, graded according to the National Cancer Institute common toxicity criteria classification (NCI CTCAE version 3.0, http://ctep.cancer.gov/reporting/ctc.html); n=39.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.